ALXN

Alexion Pharmaceuticals Inc
ALXN

Overview Fund Activity
Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

817 hedge funds and large institutions have $31.3B invested in Alexion Pharmaceuticals Inc in 2020 Q4 according to their latest regulatory filings, with 202 funds opening new positions, 238 increasing their positions, 283 reducing their positions, and 80 closing their positions.

Holders
817
Holders Change
+115
Holders Change %
+16.38%
% of All Funds
14.5%
Holding in Top 10
46
Holding in Top 10 Change
+28
Holding in Top 10 Change %
+155.56%
% of All Funds
0.82%
New
202
Increased
238
Reduced
283
Closed
80
Calls
$559M
Puts
$436M
Net Calls
+$123M
Net Calls Change
+$163M

Top Buyers

1
PCM
1
Pentwater Capital Management
Florida
$463M
2
FCM
2
Farallon Capital Management
California
$351M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$456M
4
HI
4
HBK Investments
Texas
$269M
5
Millennium Management
5
Millennium Management
New York
$294M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$982M
2
Ameriprise
2
Ameriprise
Minnesota
$367M
3
O
3
OrbiMed
New York
$26.4M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$240M
5
AQR Capital Management
5
AQR Capital Management
Connecticut
$58.6M
Name Market Value Shares Shares
Change 		Shares
Change %
KBC Group
26
KBC Group
Belgium
$257M 298,946 +116,808 +64%
T. Rowe Price Associates
27
T. Rowe Price Associates
Maryland
$240M 1,536,173 -1,579,562 -51%
Legal & General Group
28
Legal & General Group
United Kingdom
$229M 1,466,942 +39,940 +3%
AllianceBernstein
29
AllianceBernstein
Tennessee
$224M 1,435,609 -68,180 -5%
BG
30
Bellevue Group
Switzerland
$218M 1,393,028 -28,100 -2%
AAMU
31
Amundi Asset Management US
Massachusetts
$213M 1,360,498 +70,180 +5%
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$206M 1,320,277 -59,096 -4%
Deutsche Bank
33
Deutsche Bank
Germany
$205M 1,309,305 -178,594 -12%
UBS AM
34
UBS AM
Illinois
$199M 1,276,371 -316,062 -20%
MF
35
Magnetar Financial
Illinois
$184M 1,180,653 +1,180,653 New
CCM
36
Camber Capital Management
Massachusetts
$184M 1,175,000 -125,000 -10%
Franklin Resources
37
Franklin Resources
California
$182M 1,165,977 +538,775 +86%
Bank of Montreal
38
Bank of Montreal
Ontario, Canada
$181M 1,159,314 -104,562 -8%
Invesco
39
Invesco
Georgia
$179M 1,148,314 +96,795 +9%
Morgan Stanley
40
Morgan Stanley
New York
$176M 1,125,884 +479,034 +74%
Citigroup
41
Citigroup
New York
$175M 1,122,705 +279,199 +33%
Charles Schwab
42
Charles Schwab
California
$170M 1,086,933 -229,255 -17%
PHS
43
PFM Health Sciences
California
$153M 981,131 +277,314 +39%
Neuberger Berman Group
44
Neuberger Berman Group
New York
$147M 943,159 -204,277 -18%
Wells Fargo
45
Wells Fargo
California
$136M 873,464 -51,200 -6%
Man Group
46
Man Group
United Kingdom
$135M 864,994 -500,900 -37%
D.E. Shaw & Co
47
D.E. Shaw & Co
New York
$130M 833,550 +59,210 +8%
Citadel Advisors
48
Citadel Advisors
Florida
$129M 827,950 +286,243 +53%
Swiss National Bank
49
Swiss National Bank
Switzerland
$129M 827,631 -31,900 -4%
LIP
50
Liontrust Investment Partners
United Kingdom
$126M 808,900 +808,900 New
1
2
3 4 5